Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial

2020 ◽  
Author(s):  
Michael G Fehlings ◽  
Jetan H Badhiwala ◽  
Henry Ahn ◽  
H Francis Farhadi ◽  
Christopher I Shaffrey ◽  
...  
Keyword(s):  
Cervical Myelopathy ◽  
Decompressive Surgery ◽  
Phase 3 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Degenerative Cervical Myelopathy

scholarly journals Spine Treatment Appraisal Report (STAR): Does Riluzole Improve Outcomes in Patients Undergoing Decompression Surgery for Degenerative Cervical Myelopathy?

2021 ◽  
pp. 219256822199740
Author(s):  
Joseph R. Dettori
Keyword(s):  
Cervical Myelopathy ◽  
Decompressive Surgery ◽  
Decompression Surgery ◽  
Phase 3 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Degenerative Cervical Myelopathy

Fehlings MG, Badhiwala JH, Ahn H, et al. Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. Lancet Neurol. 2020.

Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial

2021 ◽  
Vol 20 (10) ◽  
pp. 821-831
Author(s):  
Merit Cudkowicz ◽  
Angela Genge ◽  
Nicholas Maragakis ◽  
Susanne Petri ◽  
Leonard van den Berg ◽  
...  
Keyword(s):  
Amyotrophic Lateral Sclerosis ◽  
Phase 3 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Lateral Sclerosis

Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial

2018 ◽  
Vol 3 (8) ◽  
pp. 537-547 ◽  
Author(s):  
Atsushi Nakajima ◽  
Mitsunori Seki ◽  
Shinya Taniguchi ◽  
Akira Ohta ◽  
Per-Göran Gillberg ◽  
...  
Keyword(s):  
Chronic Constipation ◽  
Open Label ◽  
Phase 3 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo

A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits

Vaccine ◽  
2013 ◽  
Vol 31 (28) ◽  
pp. 2963-2971 ◽  
Author(s):  
Robert A. Kuschner ◽  
Kevin L. Russell ◽  
Mary Abuja ◽  
Kristen M. Bauer ◽  
Dennis J. Faix ◽  
...  
Keyword(s):  
Adenovirus Type ◽  
Controlled Study ◽  
Phase 3 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo ◽  
Military Recruits

scholarly journals LBA-02 INTERNATIONAL PHASE 3, DOUBLE-BLIND, PLACEBO- AND ACTIVE (TOLTERODINE)-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF VIBEGRON IN PATIENTS WITH SYMPTOMS OF OVERACTIVE BLADDER: EMPOWUR

2019 ◽  
Vol 201 (Supplement 4) ◽  
Author(s):  
David Staskin* ◽  
Jeffrey Frankel ◽  
Susann Varano ◽  
Jihao Zhou ◽  
Rachael Jankowich ◽  
...  
Keyword(s):  
Overactive Bladder ◽  
Controlled Study ◽  
Phase 3 ◽  
Double Blind ◽  
Safety And Efficacy ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document